The m6A reader YTHDC2 is also critical for regulating hepatic adipogenesis and triglyceride homeostasis in NAFLD and NASH, which may provide a potential target to treat obesity-associated NAFLD (Zhou et al., 2021a). The gene discussed is YTHDC2; the disease is metabolic dysfunction-associated steatotic liver disease.